Vaxart Inc

General ticker "VXRT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $136.7M

Vaxart Inc does not follow the US Stock Market performance with the rate: -8.6%.

Estimated limits based on current volatility of 4.7%: low 0.57$, high 0.62$

Factors to consider:

  • Price in estimated range
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.42$, 1.38$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.72$, 2.00$]

Financial Metrics affecting the VXRT estimates:

  • Negative: Non-GAAP EPS, $ of -0.58 <= 0.10
  • Negative: Operating profit margin, % of -91.87 <= 1.03
  • Negative: Operating cash flow per share per price, % of -42.04 <= 2.35
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0.01 <= 0.14

Similar symbols

Short-term VXRT quotes

Long-term VXRT plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.89MM $0.11MM $7.38MM
Operating Expenses $73.64MM $114.69MM $90.73MM
Operating Income $-72.75MM $-114.59MM $-83.35MM
Non-Operating Income $2.39MM $6.90MM $1.14MM
Interest Expense $1.48MM $1.30MM $1.45MM
R&D Expense $48.75MM $81.05MM $68.14MM
Income(Loss) $-70.36MM $-107.69MM $-82.20MM
Taxes $0.11MM $0.07MM $0.26MM
Profit(Loss) $-70.47MM $-107.76MM $-82.47MM
Stockholders Equity $187.53MM $110.60MM $57.80MM
Inventory $0.00MM $2.00MM $0.00MM
Assets $221.17MM $153.85MM $91.83MM
Operating Cash Flow $-59.83MM $-94.78MM $-70.45MM
Capital expenditure $5.16MM $9.60MM $1.87MM
Investing Cash Flow $-49.10MM $-20.41MM $43.95MM
Financing Cash Flow $125.80MM $17.46MM $15.24MM
Earnings Per Share* $-0.58 $-0.84 $-0.57

* EPS are Split Adjusted, recent splits may be reflected with a delay.